Reuters logo
BRIEF-Mithra Pharmaceuticals announces first subject completes Estelle phase III study
August 18, 2017 / 5:42 AM / a month ago

BRIEF-Mithra Pharmaceuticals announces first subject completes Estelle phase III study

Aug 18 (Reuters) - MITHRA PHARMACEUTICALS SA:

* ANNOUNCES FIRST SUBJECT COMPLETES ESTELLE® PHASE III STUDY

* ESTELLE PHASE III STUDIES REMAIN ON TRACK TO REPORT TOP LINE RESULTS IN Q3 2018 AND Q1 2019 IN EUROPE/RUSSIA AND THE US/CANADA RESPECTIVELY Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below